Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases

Yoram Bujanover*, Batia Weiss

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)634-639
Number of pages6
JournalIsrael Medical Association Journal
Issue number9
StatePublished - Aug 2008


  • Children
  • Inflammatory bowel disease
  • Infliximab
  • Tumor necrosis factor

Cite this